>
Switch to:

Research Frontiers Sloan Ratio %

: 0.00% (As of Mar. 2022)
View and export this data going back to 1986. Start your Free Trial

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Research Frontiers's Sloan Ratio for the quarter that ended in Mar. 2022 was 0.00%.

Warning Sign:

When Sloan Ratio (60.34)% higher than 25% or lower than -25%, earnings are more likely to be made up of accruals.

As of Mar. 2022, Research Frontiers has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Research Frontiers Sloan Ratio % Historical Data

The historical data trend for Research Frontiers's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Research Frontiers Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Sloan Ratio %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -85.39 -14.86 -20.12 -0.56 60.34

Research Frontiers Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Sloan Ratio % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison

For the Electronic Components subindustry, Research Frontiers's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Research Frontiers Sloan Ratio % Distribution

For the Hardware industry and Technology sector, Research Frontiers's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Research Frontiers's Sloan Ratio % falls into.



Research Frontiers Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Research Frontiers's Sloan Ratio for the fiscal year that ended in Dec. 2021 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2021 )-Cash Flow from Operations (A: Dec. 2021 )
-Cash Flow from Investing (A: Dec. 2021 ))/Total Assets (A: Dec. 2021 )
=(-1.846--1.804
--2.785)/4.546
=60.34%

Research Frontiers's Sloan Ratio for the quarter that ended in Mar. 2022 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM})
-Cash Flow from Investing (TTM))/Total Assets (Q: Mar. 2022 )
=(-1.917--1.659
--0.09)/3.86
=-4.35%

Research Frontiers's Net Income for the trailing twelve months (TTM) ended in Mar. 2022 was -0.528 (Jun. 2021 ) + 0.022 (Sep. 2021 ) + -0.783 (Dec. 2021 ) + -0.628 (Mar. 2022 ) = $-1.92 Mil.
Research Frontiers's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2022 was -0.742 (Jun. 2021 ) + -0.483 (Sep. 2021 ) + 0.064 (Dec. 2021 ) + -0.498 (Mar. 2022 ) = $-1.66 Mil.
Research Frontiers's Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2022 was -3.134 (Jun. 2021 ) + 0.35 (Sep. 2021 ) + 0 (Dec. 2021 ) + 2.694 (Mar. 2022 ) = $-0.09 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Research Frontiers  (NAS:REFR) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Mar. 2022, Research Frontiers has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Research Frontiers Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Research Frontiers's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Research Frontiers Business Description

Research Frontiers logo
Industry
Technology » Hardware NAICS : 334419 SIC : 3679
Traded in Other Exchanges
N/A
Address
240 Crossways Park Drive, Woodbury, NY, USA, 11797-2033
Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. Its revenue source comes from the licensing of technology.
Executives
Douglas Family Trust 10 percent owner, other: 13(d)(3) group 125 E. SIR FRANCIS DRAKE BLVD. SUITE 400 LARKSPUR CA 94939
James & Jean Douglas Irrevocable Descendants Trust 10 percent owner, other: 13(d)(3) group 125 E. SIR FRANCIS DRAKE BLVD. SUITE 400 LARKSPUR CA 94939
Douglas Kevin 10 percent owner, other: 13(d)(3) group 125 E. SIR FRANCIS DRAKE BLVD. SUITE 400 LARKSPUR CA 94939
Settle William Graham director 6003 COBRIDGE SQUARE RALEIGH NC 27609
Lapointe Michael R officer: VP-Marketing PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: LAPOINTE MICHAEL R a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;}
Harary Joseph M director, officer: President and CEO PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: HARARY JOSEPH M a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;}
Van Voorhees Seth officer: CFO & VP-Business Development 12 HARVEY DRIVE SHORT HILLS NJ 07078
Daigle Darryl director 3213 WYTCHWOOD DRIVE MORGAN CITY LA 70380
Kaganowicz Alexander director 1217 CARLLS STRAIGHT PATH DIX HILLS NY 11746
Grimes Gregory George director 24 FIFTH AVENUE APT. 1530 NEW YORK NY 10011
Slovak Steven Michael officer: Vice President-Technology 240 CROSSWAYS PARK DRIVE WOODBURY NY 11797
Saxe Robert L director, officer: Chairman of the Board PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: SAXE ROBERT L a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;}
Keen Victor F director C/O RESEARCH FRONTIERS INC. 240 CROSSWAYS PARK DRIVE WOODBURY NY 11797
Guthrie Marion Philip director THREE LINCOLN CENTRE 5430 LBJ FWY., SUITE 1480 DALLAS TX 75240
Derby Jack director 399 BOYLSTON STREET BOSTON MA 02117

Research Frontiers Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)